PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-11-06

Date Title Company
06-Nov-2025 ClearPoint Neuro Reports Third Quarter 2025 Results ACCESS Newswire
06-Nov-2025 ClearPoint Neuro Announces Agreement to Acquire IRRAS ACCESS Newswire
06-Nov-2025 President Trump's Decision on Medical Cannabis Will Define His Legacy: Science or Marijuana Policy Stagnation ACCESS Newswire
06-Nov-2025 Endovascular Stent Grafts Market to Reach $1.76 billion by 2032, Driven by Aging Populations and Advances in Device Durability  globenewswireonlione
06-Nov-2025 Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025 ACCESS Newswire
06-Nov-2025 NHI Announces Fourth Quarter 2025 Dividend ACCESS Newswire
06-Nov-2025 NHI Issues Investor Update ACCESS Newswire
06-Nov-2025 Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update ACCESS Newswire
06-Nov-2025 NHI Announces Third Quarter 2025 Results ACCESS Newswire
06-Nov-2025 Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025 ACCESS Newswire
06-Nov-2025 Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf ACCESS Newswire
06-Nov-2025 EVERSANA Named AI Company of the Year by BioTech Breakthrough EVERSANA
06-Nov-2025 E&I Cooperative Services Awards Cenmed Enterprises Contract for Medical, Laboratory, and Sports Medicine Products ACCESS Newswire
06-Nov-2025 Venture Medical Issues Statement on CMS 2026 Physician Fee Schedule Final Rule ACCESS Newswire
06-Nov-2025 Omnix Medical and Prevail Partners, LLC Announce Strategic and Financial Partnership ACCESS Newswire
06-Nov-2025 Menopause Awards 2026 Now Open for Entries The Menopause Awards
06-Nov-2025 Oritain Accelerates Global Expansion, Supported by Laboratory Acquisitions and New Membership Model Oritain
06-Nov-2025 NEW REPORT SHOWS IICON HAS HELPED BOOST REGIONAL R&D SPEND TO OVER £1 BILLION Infection Innovation Consortium: iiCON
06-Nov-2025 Record Earnings for Gubra; Revised Outlook for the CRO Business ACCESS Newswire
06-Nov-2025 Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy Braveheart Bio